CSIMarket
 


Protalix Biotherapeutics inc   (PLX)
Other Ticker:  
 


Protalix Biotherapeutics Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



PLX Net Cash Flow Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 21.69 % -27.06 % 300.72 % -40.39 % 0.8 %
Seq. Revenue Change 1.36 % -70.51 % 265.82 % 11.27 % -39.24 %
Revenue In Millions $10.49 $10.35 $35.08 $9.59 $8.62
Net Cash Flow Margin 30.76 % -268.5 % 43.19 % - 74.17 %
Net Cash Flow Margin Total Ranking # 421 # # 524 # 333 # 441
Net Cash Flow In Millions $3.23 $-27.78 $15.15 $15.93 $6.39
Y / Y Net Cash Flow Change -49.52 % - - - -77.45 %
Seq. Net Cash Flow Change - - -4.88 % - -


Commenting fourth Quarter 2023 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in IV. Quarter to 30.76 %, below company's average Net Cash Flow Margin.

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 17 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 421.

PLX's Net Cash Flow Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 18
Healthcare Sector # 89
Overall # 421

Net Cash Flow Margin Statistics
High Average Low
2551.27 % 485.27 % 13.83 %
(Sep 30 2013)   (Mar 31 2021)




Other Net Cash Flow Margin Profitability Ratios
PLX's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
PLX's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for PLX's Competitors
Net Cash Flow Margin Profit Margin for Protalix Biotherapeutics Inc 's Suppliers
Net Cash Flow Margin Profit Margin for PLX's Customers

You may also want to know
PLX's Annual Growth Rates PLX's Profitability Ratios PLX's Asset Turnover Ratio PLX's Dividend Growth
PLX's Roe PLX's Valuation Ratios PLX's Financial Strength Ratios PLX's Net Cash Flow Growth
PLX's Roa PLX's Inventory Turnover Ratio PLX's Growth Rates PLX's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginDec 31 2023 MRQ Net Cash FlowDec 31 2023 MRQ Revenue
Curis Inc   82.08 %$ 2.213 $ 2.696 
Elutia inc   72.88 %$ 4.759 $ 6.530 
Enzon Pharmaceuticals inc   71.21 %$ 0.455 $ 0.639 
Editas Medicine Inc   68.47 %$ 41.114 $ 60.049 
Vaxart Inc   46.75 %$ 1.517 $ 3.245 
Recursion Pharmaceuticals Inc   38.73 %$ 4.218 $ 10.891 
Argenx se  32.09 %$ 800.740 $ 2,494.910 
Protalix Biotherapeutics inc   30.76 %$ 3.226 $ 10.486 
Coherus Biosciences inc   24.73 %$ 22.632 $ 91.524 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com